Zevra Therapeutics, Inc. (ZVRA) PT Raised to $21 at Roth/MKM
Tweet Send to a Friend
Roth/MKM analyst Jonathan Aschoff raised the price target on Zevra Therapeutics, Inc. (NASDAQ: ZVRA) to $21.00 (from $19.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
